Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin Dreesen

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's DiseasePeter Bossuyt, Erwin Dreesen, Jordi Rimola, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
Ebiomedicine|March 22, 2021
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trialLaurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Ebiomedicine|June 29, 2021
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens"Laurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's DiseasePeter Bossuyt, Erwin Dreesen, Jordi Rimola, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
Ebiomedicine|March 22, 2021
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trialLaurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Ebiomedicine|June 29, 2021
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens"Laurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Pageof 11